Osteoprotegerin is an Early Marker of the Fibrotic Process and of Antifibrotic Treatment Responses in Ex Vivo Lung Fibrosis.

Lung · 2024 · PMC11143060 · PMID 38642135

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Fn mRNA expression also showed a trend towards lower levels as compared to lung slices only stimulated with TGFβ1, but only after nintedanib treatment ( Fig. 5 c ) .

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.